Pharmacyclics Overview

  • Year Founded
  • 1991

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 607

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 1

Pharmacyclics General Information

Description

Developer of small-molecule drugs designed for the treatment of cancer and immune-mediated diseases. The company offers hematological oncology therapies, inhibitors, cancer treatment options, immune-mediated disease treatments, and clinical research programs, enabling healthcare providers to treat blood cancers and other serious conditions through innovative therapeutic discovery and clinical development.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1000 Gateway Boulevard
  • South San Francisco
  • San Francisco, CA 94080
  • United States
+1 (408)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • 1000 Gateway Boulevard
  • South San Francisco
  • San Francisco, CA 94080
  • United States
+1 (408)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmacyclics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Jul-2026 Completed Profitable
4. Merger/Acquisition 26-May-2015 Completed Profitable
3. PIPE 01-Aug-2006 Completed Generating Revenue/Not Profitable
2. IPO 24-Oct-1995 $25.8M $33.9M Completed Generating Revenue/Not Profitable
1. Early Stage VC 22-Apr-1994 $8.1M $8.1M Completed Product Development
To view Pharmacyclics’s complete valuation and funding history, request access »

Pharmacyclics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of small-molecule drugs designed for the treatment of cancer and immune-mediated diseases. The company offers
Drug Discovery
San Francisco, CA
607 As of 2014

Abingdon, United Kingdom
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pharmacyclics Competitors (46)

One of Pharmacyclics’s 46 competitors is Immunocore Holdings, a Formerly VC-backed company based in Abingdon, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Immunocore Holdings Formerly VC-backed Abingdon, United Kingdom
Vertex Pharmaceuticals Formerly VC-backed Boston, MA
Rein Therapeutics Formerly VC-backed Austin, TX
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Iovance Biotherapeutics Corporation San Carlos, CA
You’re viewing 5 of 46 competitors. Get the full list »

Pharmacyclics Patents

Pharmacyclics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180194762-A1 Pyrazolo[3,4-b]pyridine and pyrrolo[2,3-b]pyridine inhibitors of bruton's tyrosine kinase Inactive 06-Jan-2017
WO-2017205762-A1 Inhibitors of interleukin-1 receptor-associated kinase Inactive 27-May-2016
WO-2017205766-A1 Inhibitors of interleukin-1 receptor-associated kinase Inactive 27-May-2016
WO-2017205769-A1 Inhibitors of interleukin-1 receptor-associated kinase Inactive 27-May-2016
WO-2017087947-A2 Method of treatment of follicular lymphoma with a btk inhibitor Inactive 19-Nov-2015 A61K31/519
To view Pharmacyclics’s complete patent history, request access »

Pharmacyclics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharmacyclics Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Adams Street Partners PE/Buyout Minority
Alloy Ventures Venture Capital Minority
Asset Management Ventures Venture Capital Minority
BB Biotech Asset Manager Minority
Comdisco Ventures Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Pharmacyclics ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Pharmacyclics’s complete esg history, request access »

Pharmacyclics FAQs

  • When was Pharmacyclics founded?

    Pharmacyclics was founded in 1991.

  • Where is Pharmacyclics headquartered?

    Pharmacyclics is headquartered in San Francisco, CA.

  • What is the size of Pharmacyclics?

    Pharmacyclics has 607 total employees.

  • What industry is Pharmacyclics in?

    Pharmacyclics’s primary industry is Drug Discovery.

  • Is Pharmacyclics a private or public company?

    Pharmacyclics is a Private company.

  • What is Pharmacyclics’s current revenue?

    The current revenue for Pharmacyclics is .

  • How much funding has Pharmacyclics raised over time?

    Pharmacyclics has raised $53.9M.

  • Who are Pharmacyclics’s investors?

    Adams Street Partners, Alloy Ventures, Asset Management Ventures, BB Biotech, and Comdisco Ventures are 5 of 9 investors who have invested in Pharmacyclics.

  • Who are Pharmacyclics’s competitors?

    Immunocore Holdings, Vertex Pharmaceuticals, Rein Therapeutics, Inovio Pharmaceuticals, and Iovance Biotherapeutics are some of the 46 competitors of Pharmacyclics.

  • When was Pharmacyclics acquired?

    Pharmacyclics was acquired on 01-Jul-2026.

  • Who acquired Pharmacyclics?

    Pharmacyclics was acquired by AbbVie.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process